How does this new study fit with the two major published series on outcomes of watchful waiting in patients with asymptomatic mitral regurgitation—Rosenhek et al. (Medical University of Vienna ...

Transcatheter Mitral Valve Replacement in Atrial and Ventricular Secondary Mitral Regurgitation: Insights From the ... Up Next. Presentation NY Valves 2025. Transapical Versus Transfemoral ...

Doctors classify mitral valve regurgitation into four progressive stages. Symptoms typically don’t appear until the final stages but monitoring and treatment in earlier stages may help slow ...

Find all the latest on mitral valve regurgitation at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.

Mitral regurgitation describes when the mitral valve allows blood to flow back into a person's left atrium. Learn more about its symptoms and treatment here.

Mitral regurgitation (MR) and tricuspid regurgitation (TR) are two conditions involving backward leakage of blood through a heart valve when a ventricle contracts. People may experience either or ...

Many patients with moderate to severe functional mitral regurgitation remain symptomatic despite receiving guideline-recommended therapy. New research findings on transcatheter mitral-valve repair ...

Tricuspid regurgitation (TR) is a condition involving a leak in the tricuspid valve in your heart. An estimated 0.9% of people in the United States have this condition.

Mitral Valve Regurgitation: The valve doesn’t close completely, allowing blood to leak backward into the atrium. Mitral Valve ...

Quick Take Video Summary from The New England Journal of Medicine — Transcatheter Valve Repair for Mitral Regurgitation. Skip to main content. The New England Journal of Medicine NEJM; ...

Learn everything about mitral valve regurgitation—its causes, risk factors, stages, symptoms, and treatment options—in this complete and informative guide ...

Transapical mitral valve replacement by catheter eliminated mitral regurgitation and improved hemodynamics in a frail high-risk population, results of the SUMMIT trial show.